These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34927338)

  • 1. The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression.
    Gulay KCM; Aoshima K; Kim S; Kitaguchi R; Kobayashi A; Kimura T
    Vet Comp Oncol; 2022 Jun; 20(2):529-534. PubMed ID: 34927338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM2B promotes cell viability by enhancing DNA damage response in canine hemangiosarcoma.
    Gulay KCM; Aoshima K; Shibata Y; Yasui H; Yan Q; Kobayashi A; Kimura T
    J Genet Genomics; 2021 Jul; 48(7):618-630. PubMed ID: 34023294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of monocyte recruitment in hemangiosarcoma metastasis in dogs.
    Regan DP; Escaffi A; Coy J; Kurihara J; Dow SW
    Vet Comp Oncol; 2017 Dec; 15(4):1309-1322. PubMed ID: 27779362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
    Burton JH; Powers BE; Biller BJ
    Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between CXCR4 and CXCL12 promote cell migration and invasion of canine hemangiosarcoma.
    Im KS; Graef AJ; Breen M; Lindblad-Toh K; Modiano JF; Kim JH
    Vet Comp Oncol; 2017 Jun; 15(2):315-327. PubMed ID: 26337509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulating histone acetylation leads to antitumor effects in hemangiosarcoma cells.
    Suzuki T; Aoshima K; Yamazaki J; Kobayashi A; Kimura T
    Vet Comp Oncol; 2022 Dec; 20(4):805-816. PubMed ID: 35568976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of tumour-related factors associated with canine retroperitoneal hemangiosarcoma in comparison with other anatomic presentations: A retrospective observational study.
    Furukawa T; Shiotsuki A; Okada Y; Nibe K; Tei M; Anazawa T; Yoshikawa M; Ono K; Hirao H
    Vet Med Sci; 2024 Jul; 10(4):e1495. PubMed ID: 38889089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
    Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
    Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages.
    Gulay KCM; Aoshima K; Maekawa N; Suzuki T; Konnai S; Kobayashi A; Kimura T
    Sci Rep; 2022 Feb; 12(1):2124. PubMed ID: 35136176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and adverse events of anthracycline and propranolol combination in five dogs with stage 3 hemangiosarcoma.
    Terauchi M; Fujii Y; Goto S; Iwasaki R; Yoshikawa R; Mori T
    Open Vet J; 2023 Jun; 13(6):801-806. PubMed ID: 37545711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine demethylase 2B regulates angiogenesis via Jumonji C dependent suppression of angiogenic transcription factors.
    Sasaki Y; Higashijima Y; Suehiro JI; Sugasawa T; Oguri-Nakamura E; Fukuhara S; Nagai N; Hirakawa Y; Wada Y; Nangaku M; Kanki Y
    Biochem Biophys Res Commun; 2022 May; 605():16-23. PubMed ID: 35306360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.
    Mukai C; Choi E; Sams KL; Klampen EZ; Anguish L; Marks BA; Rice EJ; Wang Z; Choate LA; Chou SP; Kato Y; Miller AD; Danko CG; Coonrod SA
    BMC Vet Res; 2020 Jun; 16(1):206. PubMed ID: 32571313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
    Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
    Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.
    Witter LE; Gruber EJ; Lean FZ; Stokol T
    Am J Vet Res; 2017 Jan; 78(1):69-79. PubMed ID: 28029283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular atypia is negatively correlated with immunohistochemical reactivity of CD31 and vWF expression levels in canine hemangiosarcoma.
    Maharani A; Aoshima K; Onishi S; Gulay KCM; Kobayashi A; Kimura T
    J Vet Med Sci; 2018 Feb; 80(2):213-218. PubMed ID: 29311493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative aspects and clinical outcomes of canine renal hemangiosarcoma.
    Locke JE; Barber LG
    J Vet Intern Med; 2006; 20(4):962-7. PubMed ID: 16955823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Hemangiosarcoma of the Falciform Fat in Seven Dogs (2007-2015).
    Mendez SE; Sykes Crumplar SE; Durham AC
    J Am Anim Hosp Assoc; 2020; 56(2):120-126. PubMed ID: 31961215
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma.
    Rodriguez AM; Graef AJ; LeVine DN; Cohen IR; Modiano JF; Kim JH
    J Vet Intern Med; 2015; 29(4):1088-97. PubMed ID: 26118793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big endothelin-1 as a tumour marker for canine haemangiosarcoma.
    Fukumoto S; Miyasho T; Hanazono K; Saida K; Kadosawa T; Iwano H; Uchide T
    Vet J; 2015 Jun; 204(3):269-74. PubMed ID: 25920760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.
    Lucroy MD; Clauson RM; Suckow MA; El-Tayyeb F; Kalinauskas A
    BMC Vet Res; 2020 Nov; 16(1):447. PubMed ID: 33208160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.